Keyphrases
Colombians
92%
Next-generation Sequencing
60%
Colombian Patients
52%
Clopidogrel
47%
Pharmacological Analysis
45%
Premature Ovarian Failure
45%
Colombia
39%
Platelet Reactivity
36%
Polymorphism
36%
Breast Cancer
27%
Whole Exome Sequencing
27%
High On-treatment Platelet Reactivity
27%
Colorectal Cancer
27%
Allele Frequency
27%
Coding Region
23%
Population Genetics
22%
Mayors
22%
Inter-individual Variability
22%
Genetic Profile
21%
Novel mutation
20%
Exome Sequencing
20%
New mutation
20%
COVID-19
19%
Genetic Analysis
19%
Pathogenic Variants
19%
Ataxia
19%
Genetic Approach
18%
Acute Coronary Syndrome
18%
CYP2C19
18%
Leptin Deficiency
18%
Molecular Neuroscience
18%
New Risks
18%
Amplified Fragment Length Polymorphism
18%
Ocular Apraxia
18%
Ebstein Anomaly
18%
Sequence Analysis
18%
Genome Analysis
18%
Sequence Variants
17%
Clinical Genetics
16%
Molecular Variants
16%
Latin American Countries
16%
Adverse Drug Reaction
16%
CYP2C9
16%
Breast Cancer Susceptibility Gene 1 (BRCA1)
16%
Sanger Sequencing
16%
Molecular Diagnostics
16%
X Chromosome
15%
Single nucleotide Polymorphism
14%
Closure Time
14%
Molecular Mechanism
14%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Next Generation Sequencing
67%
Clopidogrel
55%
Pharmacogenetic Testing
50%
Exome Sequencing
46%
Platelet Reactivity
36%
Population Genetics
31%
Genetic Determinism
28%
Allele
27%
Genetic Divergence
26%
Gene Frequency
26%
Coding Region
24%
BRCA1
22%
Genomics
22%
Microsatellite DNA
22%
Germline
20%
Germ Cell
20%
Dideoxynucleotide Sequencing
19%
Missense Mutation
19%
Genetic Variation
19%
Genetic Approach
18%
CYP2C19
18%
Leptin
18%
Shotgun Sequencing
18%
Protein Sequencing
18%
Promoter Region
18%
Missense
17%
BRCA2
16%
Exome
16%
Pharmacogenetics
16%
X Chromosome
15%
Gene Expression
14%
SARS Coronavirus
14%
Metabolic Pathway
13%
Candidate Gene
13%
Exon
13%
Pharmacogenomics
12%
Bioinformatics
12%
Medical Genetics
12%
Medical Genomics
12%
Comorbidity
12%
Single-Nucleotide Polymorphism
11%
Luciferase
11%
Indel
11%
Genetic Risk
11%
CYP2C9
11%
Reporter Gene
11%
Expression Analysis
11%
Transcription Factor
10%
Pharmacogenetic Variant
10%
